Douglas Hughes

Douglas Hughes

Direktör/Styrelseledamot på IMMUNOVANT, INC.

Förmögenhet: 5 M $ per 2026-07-31

64 år
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Douglas Hughes is Director at Immunovant Sciences Ltd. since 2019.
Mr. Hughes is Independent Director at Immunovant, Inc. since 2019.
Mr. Hughes is Chief Financial Officer & Director at Calyxo, Inc. since 2018.
Mr. Hughes is Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former positions include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-06-30 120 773 ( 0,06 % ) 5 M $ 2026-07-31

Aktiva positioner av Douglas Hughes

FöretagPositionStart
IMMUNOVANT, INC. Direktör/Styrelseledamot 2019-12-18
Finansdirektör/CFO 2019-01-01
Direktör/Styrelseledamot 2019-10-01
Finansdirektör/CFO 2018-01-01

Tidigare kända positioner av Douglas Hughes

FöretagPositionSlut
EARGO, INC. Direktör/Styrelseledamot 2022-12-07
Finansdirektör/CFO 2018-01-01
Offentlig kommunikationskontakt 2011-04-01
Finansdirektör/CFO 2011-01-01
Finansdirektör/CFO 2010-01-01
Se detaljerna i Douglas Hughess erfarenhet

Douglas Hughess utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

70

Första gradens relationer

15

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag15

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Distribution Services

Industrial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Douglas Hughes